American Heart Association launches initiative to engage pharmacists in atrial fibrillation care

Atrial fibrillation, or AFib, is the most common type of irregular heartbeat, estimated to affect about 12.1 million U.S. adults by 2030.

Related Keywords

United States ,American ,Cody Parsons ,Stanford Health Care ,Bristol Myers Squibb ,American Heart Association ,Pfizer Alliance ,Atrial Fibrillation ,Bristol Myers Squibb Pfizer ,Anticoagulant ,Heart ,Stroke ,